Welcome to CDC stacks | SUPPLEMENTARY TABLE 2. Prespecified outcomes*,† for recombinant zoster vaccine (RZV) in reports submitted to the Vaccine Adverse Events Reporting System (VAERS) — United States, October 2017–June 2018 - 61561 | Morbidity and Mortality Weekly Report (MMWR)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
SUPPLEMENTARY TABLE 2. Prespecified outcomes*,† for recombinant zoster vaccine (RZV) in reports submitted to the Vaccine Adverse Events Reporting System (VAERS) — United States, October 2017–June 2018
  • Published Date:
    February 1, 2019
  • Source:
    MMWR. Morbidity and mortality weekly report ; v. 68, no. 4
  • Language:
    English


Public Access Version Available on: January 31, 2019 information icon
Please check back on the date listed above.
Details:
  • Supporting Files:
    No Additional Files
You May Also Like:
  1. Coming Soon
    SUPPLEMENTARY TABLE 1. Search strategy to identify recombinant zoster vaccine (RZV) reports of selected pre-specified outcomes in the Vaccine Adverse Events Reporting System (VAERS) — United States, October 2017–June 2018
    Published:
    February 1, 2019
    Source:
    MMWR. Morbidity and mortality weekly report ; v. 68, no. 4
    Description:
    Supplements: Post-licensure safety surveillance of recombinant zoster vaccine (Shingrix) —Vaccine Adverse Event Reporting System (VAERS), United States, October 2017–June 2018
    Public Access
    Available on:
    January 31, 2019
  2. Herpes Zoster Vaccination : update
    Personal Author:
    Dooling, Kathleen
    Corporate Author:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Conference Author:
    United States. Advisory Committee on Immunization Practices. Meeting (2018 June 20-21 : Atlanta, GA)
    Published:
    8/9/18
    Series:
    ACIP meeting Herpes Zoster Vaccine
    Description:
    Presentations June 2018 Day 1 : Publication date from document properties.
    File Type:
    Filetype[PDF - 806.93 KB]
  3. Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
    Personal Author:
    Dooling, Kathleen L.; Guo, Angela; Patel, Manisha; Lee, Grace M.; Moore, Kelly; Belongia, Edward A.; Harpaz, Rafael;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Published:
    Jan 26 2018
    Source:
    MMWR Morb Mortal Wkly Rep. 67(3):103-108.; Published also as: Am J Transplant. 2018 Mar;18(3):756-762. doi: 10.1111/ajt.14683. (PMID: 29462512).;
    Description:
    On October 20, 2017, Zoster Vaccine Recombinant, Adjuvanted (Shingrix, GlaxoSmithKline, [GSK] Research Triangle Park, North Carolina), a 2-dose, subunit vaccine containing recombinant glycoprotein E in combination with a novel adjuvant (AS01|), was a...
    File Type:
    Filetype[PDF - 114.29 KB]
  4. MMWR. Morbidity and mortality weekly report, Vol. 67, no. 3, January 26, 2018
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    January 26, 2018
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 67, no. 3
    Description:
    Short Sleep Duration Among Middle School and High School Students — United States, 2015 -- Population-Based Surveillance of Birth Defects Potentially Related to Zika Virus Infection — 15 States and U.S. Territories, 2016 -- State-Specific Prevale...
    File Type:
    Filetype[PDF - 553.57 KB]
  5. MMWR. Morbidity and mortality weekly report, Vol. 67, no. 20, May 25, 2018
    Published:
    May 25, 2018
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 67, no. 20
    Description:
    HIV Preexposure Prophylaxis in the U.S. Military Services — 2014–2016 / Jason M. Blaylock, MD; Shilpa Hakre, DrPH; Jason F. Okulicz, MD; et al. -- Use of Outpatient Rehabilitation Among Adult Stroke Survivors — 20 States and the District of Col...
    File Type:
    Filetype[PDF - 1.77 MB]